-
Symbol
-
SGMT on Nasdaq
-
Investment type
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
1,504,642 shares
-
Security Ownership %
-
4.9%
AP11 Limited ownership in Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT)
24 Jun 2025 - AP11 Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,504,642 shares of Sagimet Biosciences Inc. Series A Common Stock, $0.0001 par value per share (SGMT).
This represents 4.9% ownership of the company.
In their previous filing dated 20 May 2025, AP11 Ltd had reported owning 1,654,701 shares, indicating a decrease of +9.1%.
.